145 related articles for article (PubMed ID: 9884519)
41. [Reduction of the physiologic IOP value after instilation of the mixture of the 2 amino acid's (L-lysine and L-arginine) in timoptol--experiment on rabbit's].
Veselovský J; Oláh Z; Veselá A; Gressnerová S
Cesk Slov Oftalmol; 2006 Jan; 62(1):3-10. PubMed ID: 16491635
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
[TBL] [Abstract][Full Text] [Related]
43. [Modification in amplitude of nycthemeral changes in intraocular pressure under timolol].
Martin X; Rabineau PA
J Fr Ophtalmol; 1988; 11(12):843-8. PubMed ID: 3075625
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
Plummer CE; MacKay EO; Gelatt KN
Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma.
Volopich S; Mosing M; Auer U; Nell B
Vet Ophthalmol; 2006; 9(4):239-44. PubMed ID: 16771759
[TBL] [Abstract][Full Text] [Related]
46. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
[TBL] [Abstract][Full Text] [Related]
47. Adrenergic drugs and intraocular pressure: suppression of ocular hypertension induced by water loading.
Rowland JM; Potter DE
Exp Eye Res; 1980 Jan; 30(1):93-104. PubMed ID: 6102526
[No Abstract] [Full Text] [Related]
48. Additive intraocular pressure reducing effect of topical timolol during systemic beta-blockade.
Marén N; Alvan G; Calissendorff BM; Haglund K; Seideman P
Acta Ophthalmol (Copenh); 1982 Feb; 60(1):16-23. PubMed ID: 6127860
[TBL] [Abstract][Full Text] [Related]
49. The effect of timolol on anterior-chamber oxygenation.
Pakalnis VA; Rustgi AK; Stefansson E; Wolbarsht ML; Landers MB
Ann Ophthalmol; 1987 Aug; 19(8):298-300. PubMed ID: 3662313
[TBL] [Abstract][Full Text] [Related]
50. Effects of D-timolol on intraocular pressure, heart rate, cardiac contractility, and tracheal muscle function.
Chiou GC
Curr Eye Res; 1982-1983; 2(8):507-10. PubMed ID: 7184703
[TBL] [Abstract][Full Text] [Related]
51. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
[TBL] [Abstract][Full Text] [Related]
52. In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment.
Andreadis II; Karavasili C; Thomas A; Komnenou A; Tzimtzimis M; Tzetzis D; Andreadis D; Bouropoulos N; Fatouros DG
Mol Pharm; 2022 Jan; 19(1):274-286. PubMed ID: 34877863
[TBL] [Abstract][Full Text] [Related]
53. Discoidal niosome based controlled ocular delivery of timolol maleate.
Vyas SP; Mysore N; Jaitely V; Venkatesan N
Pharmazie; 1998 Jul; 53(7):466-9. PubMed ID: 9742041
[TBL] [Abstract][Full Text] [Related]
54. Adrenergic beta-receptor blockers, adrenalin and intraocular pressure.
Ohrström A
Acta Ophthalmol Suppl; 1982; 150():4-58. PubMed ID: 6123215
[No Abstract] [Full Text] [Related]
55. Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system.
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biol Pharm Bull; 2008 May; 31(5):970-5. PubMed ID: 18451528
[TBL] [Abstract][Full Text] [Related]
56. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
[TBL] [Abstract][Full Text] [Related]
57. R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
Share NN; Lotti VJ; Gautheron P; Schmitt C; Gross DM; Hall RA; Stone CA
Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):234-8. PubMed ID: 6092239
[TBL] [Abstract][Full Text] [Related]
58. Ocular and cardiac beta-antagonism by timolol prodrugs, timolol and levobunolol.
Potter DE; Shumate DJ; Bundgaard H; Lee VH
Curr Eye Res; 1988 Aug; 7(8):755-9. PubMed ID: 2903009
[TBL] [Abstract][Full Text] [Related]
59. Optic nerve vasomotor effects of topical beta-adrenergic antagonists in rabbits.
Orgül S; Mansberger S; Bacon DR; Van Buskirk EM; Cioffi GA
Am J Ophthalmol; 1995 Oct; 120(4):441-7. PubMed ID: 7573301
[TBL] [Abstract][Full Text] [Related]
60. Effect of timolol on intra-ocular pressure in the presence of systemic propranolol in healthy subjects.
Sud RN; Kataria AK
Indian J Ophthalmol; 1985; 33(4):225-7. PubMed ID: 3842830
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
